NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Sees Large Decrease in Short Interest

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) was the recipient of a significant drop in short interest during the month of February. As of February 28th, there was short interest totalling 2,600 shares, a drop of 31.6% from the February 13th total of 3,800 shares. Based on an average daily volume of 65,900 shares, the short-interest ratio is presently 0.0 days.

NLS Pharmaceutics Trading Down 3.0 %

Shares of NLS Pharmaceutics stock traded down $0.00 during trading on Monday, hitting $0.01. 16,172 shares of the company’s stock were exchanged, compared to its average volume of 63,486. The business has a 50-day simple moving average of $0.01 and a 200-day simple moving average of $0.01. NLS Pharmaceutics has a 52-week low of $0.01 and a 52-week high of $0.09.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).